In the six years since publication of the evidence-based TFOS DEWS II reports¹, awareness and acknowledgement of dry eye disease (DED) as a growing global concern has continued to intensify. These reports reached consensus with respect to the diagnosis, classification, diagnosis and management of DE
The Ocular Surface Laboratory’s team of clinician scientists at the University of Auckland is dedicated to improving patient outcomes through developing a better understanding of ocular surface and
Bausch + Lomb (B+L) has acquired Johnson & Johnson Vision’s Blink product line of over-the-counter (OTC) eye and contact lens drops. “There’s a growing need for relieving the symptoms of dry eyes and
Developed by internationally renowned ocular surface educators Professors Jennifer Craig (New Zealand), Lyndon Jones (Canada) and James Wolffsohn (UK), the World Council of Optometry (WCO) and Alcon’s
Calling all budding dry-eye specialists! The University of Auckland is running a special FREE event to upgrade your dry-eye knowledge and management strategy on Thursday 20 July
The Tear Film & Ocular Surface Society (TFOS) is asking optometry practice owners what their current diagnosis and management approaches to dry eye are in a second survey linked to the TFOS dry eye
Sun Pharma’s Cequa (ciclosporin 900μg/ml) eyedrop has been listed on Australia’s Pharmaceutical Benefits Scheme (PBS) for patients with chronic, severe dry eye disease (DED) with keratitis. Cequa’s
Miebo, a single-ingredient tear stabiliser from Bausch + Lomb and Novaliq, has been given the green light by the US Food and Drug Administration (FDA), offering a new treatment for dry eye disease
Not long ago, award-winning Libyan-American journalist Noor Tagouri shared her family’s dry-eye disease (DED) remedy of onion vapour and honey. Onion enzymes and sulfenic acid combine to produce propanethial S-oxide, which is detected by corneal nerves and ultimately leads to aqueous secretion from
Dry eye was the focus for Titan Optical’s Cam Gordon, who shared a table with Medix21’s Camille Furnandiz at CCLS. In the spotlight was Rayner’s co-marketed Aeon pre- and post-surgery eye drops to help manage dry eye disease (DED), and OcuSci’s new eye mask and meibomian gland treatment kit, MGrx.
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI), US, developed a prototype contact lens designed to prevent contact lens-induced dry eye (CLIDE) by facilitating tear flow in
